Safety and immunogenicity of co-administration of meningococcal type A and measles–rubella vaccines with typhoid conjugate vaccine in children aged 15–23 months in Burkina Faso

Safety and immunogenicity of co-administration of meningococcal type A and measles–rubella vaccines with typhoid conjugate vaccine in children aged 15–23 months in Burkina Faso

Objectives: The World Health Organization pre-qualified single-dose typhoid conjugate vaccine (TCV) and requested data on co-administration with routine vaccines. The co-administration of Typbar TCV (Bharat Biotech International) with routine group A meningococcal conjugate vaccine (MCV-A) and measl...

Full description

Bibliographic Details
Main Authors: Sodiomon B. Sirima, Alphonse Ouedraogo, Nouhoun Barry, Mohamadou Siribie, Alfred B. Tiono, Issa Nébié, Amadou T. Konaté, Gloria Damoaliga Berges, Amidou Diarra, Moussa Ouedraogo, Issiaka Soulama, Alimatou Hema, Shrimati Datta, Yuanyuan Liang, Elizabeth T. Rotrosen, J. Kathleen Tracy, Leslie P. Jamka, Kathleen M. Neuzil, Matthew B. Laurens
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:International Journal of Infectious Diseases
Subjects:
Typhoid conjugate vaccine
Meningococcal vaccines
Measles–rubella vaccine
Co-administration
Sub-Saharan Africa
Burkina Faso
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971220323092

Internet

http://www.sciencedirect.com/science/article/pii/S1201971220323092

Similar Items